BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 13536861)

  • 1. Vasopressor agents; influence of acidosis on cardiac and vascular responsiveness.
    WEIL MH; HOULE DB; BROWN EB; CAMPBELL GS; HEATH C
    Calif Med; 1958 Jun; 88(6):437-40. PubMed ID: 13536861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of respiratory acidosis on ECG and pressor responses to epinephrine, norepinephrine and metaraminol.
    HOULE DB; WEIL MH; BROWN EB; CAMPBELL GS
    Proc Soc Exp Biol Med; 1957 Mar; 94(3):561-4. PubMed ID: 13408326
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies on a vasopressor agent: metaraminol (aramine). II. Observations on its use in the management of shock.
    WEIL MH
    Am J Med Sci; 1955 Oct; 230(4):357-69. PubMed ID: 13258566
    [No Abstract]   [Full Text] [Related]  

  • 4. PRESSOR AMINES AND ANGIOTENSIN IN THE TREATMENT OF SHOCK.
    UDHOJI VN; WEIL MH; SAMBHI MP
    Int Anesthesiol Clin; 1964 Feb; 2():399-419. PubMed ID: 14125018
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vasopressor action of some adrenergic amines in animals in experimental cardiac arrest].
    Pietrobono P; Bragheri R; Berizzi GF
    Acta Anaesthesiol; 1968; 19():Suppl 9:65-72. PubMed ID: 5757555
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pressor amines and cardiogenic shock. An evalution with special reference to the use of noradrenaline].
    Hillestad L
    Tidsskr Nor Laegeforen; 1965 Nov; 85(21):1621-4. PubMed ID: 5882929
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasopressor-cardiotonic drugs in cardiac resuscitation.
    Jude JR; Neumaster T; Kfoury E
    Acta Anaesthesiol Scand Suppl; 1968; 29():147-63. PubMed ID: 5674565
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sympathomimetic amines of current use. Cardiocirculatory effect in normal dogs. Observations].
    Aquino AB
    Hospital (Rio J); 1968 Nov; 74(5):1543-52. PubMed ID: 5305332
    [No Abstract]   [Full Text] [Related]  

  • 9. HEMODYNAMIC EFFECTS OF PRESSOR AGENTS IN SEPTIC AND MYOCARDIAL INFARCTION SHOCK.
    SMULYAN H; CUDDY RP; EICH RH
    JAMA; 1964 Oct; 190():188-94. PubMed ID: 14246588
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of sympathomimetic amines in shock.
    Goldberg LI
    Am Fam Physician; 1974 Jul; 10(1):80-5. PubMed ID: 4152035
    [No Abstract]   [Full Text] [Related]  

  • 11. PHARMACOLOGIC APPROACH TO THE TREATMENT OF SHOCK.
    AVIADO DM
    Ann Intern Med; 1965 May; 62():1050-9. PubMed ID: 14283384
    [No Abstract]   [Full Text] [Related]  

  • 12. A COMPARISON OF THE CARDIAC STIMULATING AND BRONCHODILATOR ACTIONS OF SELECTED SYMPATHOMIMETIC AMINES.
    LANDS AM; BROWN TG
    Proc Soc Exp Biol Med; 1964 Jun; 116():331-3. PubMed ID: 14193360
    [No Abstract]   [Full Text] [Related]  

  • 13. The adjuvant use of pressor amines during cardiac massage.
    Rothwell-Jackson RL
    Br J Surg; 1968 Jul; 55(7):545-50. PubMed ID: 5663440
    [No Abstract]   [Full Text] [Related]  

  • 14. Sympathomimetic agents in the treatment of shock.
    Tarazi RC
    Ann Intern Med; 1974 Sep; 81(3):364-71. PubMed ID: 4605195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cardiac shock by metaraminol.
    BESTERMAN EM
    Br Med J; 1959 Apr; 1(5129):1081-3. PubMed ID: 13638636
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical studies on vasopressor agent: metaraminol (aramine). III. Observations on its oral use in the treatment of hypotension.
    WEIL MH
    Am J Med Sci; 1957 Apr; 233(4):367-74. PubMed ID: 13410911
    [No Abstract]   [Full Text] [Related]  

  • 17. THE EFFICACY AND ADVERSE EFFECTS OF VASOCONSTRICTORS USED AS ADJUNCTS IN REGIONAL ANESTHESIA.
    STENENSON A; ADRIANI J; HYDE E
    Anesth Analg; 1964; 43():495-500. PubMed ID: 14209303
    [No Abstract]   [Full Text] [Related]  

  • 18. The inhibitory influence of lactic acid on pressor effects of sympathomimetic amines.
    LITWIN J; JANCZEWSKA H; BIELECKI K
    Pol Med Sci Hist Bull; 1963 Apr; 6():70-2. PubMed ID: 13931016
    [No Abstract]   [Full Text] [Related]  

  • 19. The dilemma of vasopressors and vasodilators in the therapy of shock.
    Shoemaker WC; Brown RS
    Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic spectrum of vasopressor and vasodilator drugs.
    Lewis CM; Weil MH
    JAMA; 1969 May; 208(8):1391-8. PubMed ID: 4307223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.